Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP-xylose 4-epimerase (UXE), also known as UDP-L-arabinose 4-epimerase, is an enzyme that catalyzes the reversible interconversion of UDP-D-xylose and UDP-L-arabinose [1, 3, 5]. This enzyme is primarily found in plants, fungi, and certain bacteria, where it plays a critical role in the biosynthesis of cell wall polysaccharides and extracellular glycans [5, 6, 30]. In plants, it provides the UDP-L-arabinose required for the synthesis of pectins and hemicelluloses, while in pathogenic microorganisms, it is involved in the production of surface polysaccharides essential for biofilm formation and virulence [1, 3, 11]. Because UXE is not present in humans, it is considered a promising target for the development of novel anti-infective agents, particularly against antibiotic-resistant bacteria and pathogenic fungi [1, 11]. Inhibition of this enzyme can disrupt the structural integrity of the pathogen or reduce its ability to form protective biofilms, thereby enhancing the host's immune response or the efficacy of co-administered treatments [3, 11]. Current research efforts are focused on identifying selective small-molecule inhibitors that can distinguish between the pathogen's UXE and human UDP-sugar epimerases, such as UDP-glucose 4-epimerase (GALE), to minimize potential off-target effects [4, 11].
Inhibition of the interconversion between UDP-xylose and UDP-arabinose, which disrupts the synthesis of essential cell wall or surface polysaccharides in pathogens [1, 11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-xylose 4-epimerase (UXE).